- Home
- ANAB vs WEST Comparison
ANAB vs WEST Comparison
Compare ANAB & WEST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANAB
- WEST
- Stock Information
- Founded
- ANAB 2005
- WEST 2009
- Country
- ANAB United States
- WEST United States
- Employees
- ANAB N/A
- WEST N/A
- Industry
- ANAB Biotechnology: Pharmaceutical Preparations
- WEST Beverages (Production/Distribution)
- Sector
- ANAB Health Care
- WEST Consumer Staples
- Exchange
- ANAB Nasdaq
- WEST Nasdaq
- Market Cap
- ANAB 600.4M
- WEST 601.4M
- IPO Year
- ANAB 2017
- WEST N/A
- Fundamental
- Price
- ANAB $22.27
- WEST $7.89
- Analyst Decision
- ANAB Buy
- WEST Strong Buy
- Analyst Count
- ANAB 11
- WEST 5
- Target Price
- ANAB $54.64
- WEST $12.20
- AVG Volume (30 Days)
- ANAB 623.5K
- WEST 66.8K
- Earning Date
- ANAB 11-05-2024
- WEST 11-07-2024
- Dividend Yield
- ANAB N/A
- WEST N/A
- EPS Growth
- ANAB N/A
- WEST N/A
- EPS
- ANAB N/A
- WEST N/A
- Revenue
- ANAB $57,172,000.00
- WEST $836,715,000.00
- Revenue This Year
- ANAB $207.49
- WEST $5.15
- Revenue Next Year
- ANAB N/A
- WEST $28.78
- P/E Ratio
- ANAB N/A
- WEST N/A
- Revenue Growth
- ANAB 282.17
- WEST N/A
- 52 Week Low
- ANAB $13.36
- WEST $5.28
- 52 Week High
- ANAB $41.31
- WEST $11.21
- Technical
- Relative Strength Index (RSI)
- ANAB 42.41
- WEST 65.86
- Support Level
- ANAB $18.03
- WEST $6.34
- Resistance Level
- ANAB $22.94
- WEST $6.97
- Average True Range (ATR)
- ANAB 1.37
- WEST 0.43
- MACD
- ANAB 0.45
- WEST 0.06
- Stochastic Oscillator
- ANAB 86.18
- WEST 99.36
About ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
About WEST Westrock Coffee Company
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.